Search Within

Elisa De Stanchina

  1. "Ronald Hendrickson"
Formats
  1. Journal Article (5)
  2. Meeting Abstract (3)
Groups
  1. Sloan Kettering Institute Postdocs (8)
  2. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (6)
  3. Center for Hematologic Malignancies (6)
  4. Center for Pancreatic Cancer Research (6)
  5. Department of Medicine (6)
  6. Executive Committee, Center for Hematologic Malignancies (6)

More Groups

People
  1. Ronald Hendrickson (8)
  2. Anas Younes (4)
  3. Enrico Derenzini (4)
  4. John Philip (4)
  5. Patrizia Mondello (4)
  6. Venkatraman Seshan (4)

More People

Years
  1. 2023 (1)
  2. 2022 (2)
  3. 2019 (1)
  4. 2018 (1)
  5. 2017 (1)
  6. 2016 (2)
Publications
  1. Blood (2)
  2. Cancer Research Communications (1)
  3. Cell (1)
  4. Cell Reports (1)
  5. Clinical Cancer Research (1)
  6. Oncotarget (1)

More Publications

Publishers
  1. American Association for Cancer Research (2)
  2. American Society of Hematology (2)
  3. Cell Press (2)
  4. Impact Journals (1)
  5. Nature Publishing Group (1)

Results (8)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A druggable FOXA1-glucocorticoid receptor transcriptional axis drives tumor growth in a subset of non-small cell lung cancer
    Journal Article

    Dorso, M.; Patel, P. T.; Pankov, A.; Boyer, J. A.; Soni, R. K.; Del Priore, I. S.; Hayatt, O.; Kulick, A.; Hagen, C. J.; de Stanchina, E.; more...
    Cancer Research Communications (2023)

    Fulltext@MSK | Save
  • Targeting non-canonical Hippo pathway in NRF2-mutant liver cancer
    Meeting Abstract

    Sanghvi, V.; Rust, A.; Leibold, J.; Lowe, S.; Viale, A.; Chodera, J.; Hendrickson, R. C.; de Stanchina, E.; Wendel, H. G.
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save
  • ERα-LBD, an isoform of estrogen receptor alpha, promotes breast cancer proliferation and endocrine resistance
    Journal Article

    Strillacci, A.; Sansone, P.; Rajasekhar, V. K.; Turkekul, M.; Boyko, V.; Meng, F.; Houck-Loomis, B.; Brown, D.; Berger, M. F.; Hendrickson, R. C.; more...
    npj Breast Cancer (2022)

    Fulltext@MSK | Save
  • The oncogenic action of NRF2 depends on de-glycation by fructosamine-3-kinase
    Journal Article

    Sanghvi, V. R.; Leibold, J.; Mina, M.; Mohan, P.; Berishaj, M.; Li, Z.; Miele, M. M.; Lailler, N.; Zhao, C.; de Stanchina, E.; more...
    Cell (2019)

    Fulltext@MSK | Save
  • BET inhibition-induced GSK3β feedback enhances lymphoma vulnerability to PI3K inhibitors
    Journal Article

    Derenzini, E.; Mondello, P.; Erazo, T.; Portelinha, A.; Liu, Y.; Scallion, M.; Asgari, Z.; Philip, J.; Hilden, P.; Valli, D.; more...
    Cell Reports (2018)

    Fulltext@MSK | Save
  • Dual inhibition of histone deacetylases and phosphoinositide 3-kinase enhances therapeutic activity against B cell lymphoma
    Journal Article

    Mondello, P.; Derenzini, E.; Asgari, Z.; Philip, J.; Brea, E. J.; Seshan, V.; Hendrickson, R. C.; de Stanchina, E.; Scheinberg, D. A.; Younes, A.
    Oncotarget (2017)

    Fulltext@MSK | Save
  • Dual inhibition of histone deacetylases and phosphoinositide 3-kinase enhances therapeutic activity against B cell lymphoma
    Meeting Abstract

    Mondello, P.; Derenzini, E.; Asgari, Z.; Philip, J.; Brea, E. J.; Seshan, V. E.; Hendrickson, R.; de Stanchina, E.; Scheinberg, D. A.; Younes, A.
    Blood (2016)

    Fulltext@MSK | Save
  • MYC-dependent PI3K and MCL-1 feedbacks attenuate BET inhibitors activity in diffuse large B-cell lymphoma
    Meeting Abstract

    Derenzini, E.; Mondello, P.; Liu, Y.; Scallion, M.; Asgari, Z.; Philip, J.; Hilden, P.; Djaballah, H.; Ouerfelli, O.; de Stanchina, E.; more...
    Blood (2016)

    Fulltext@MSK | Save